All Type of News


Early business entry of Zuellig to domestic drug markets unclear.

Zuellig, a Swiss pharmaceutical wholesale company, planned to make a market entry into Korea during the first half of this year, but it seems to be very unclear, although they had tried to speed up their business laun...

Insurance reimbursement for 615 new drugs approved.

As of April 1, 1999 the MOHW approved new insurance reimbursements for 615 products. (see YK data reference No. 12) 615 items included 6 new drugs of chemical entities by 5 companies, 609 products by 98 companies i...

Drug distribution community to restrain issuance of payment note.

The local drug wholesalers have indulged themselves in expanding their sales volume without much care of profits, and for this objective they issued too payment notes, which eventually turned back and killed themselve...

Domestic drug maker keenly interested in new drug development.

Many research oriented domestic drug makers have made quite an investment for a new drug development since long time, and as a result, several new drugs seem to appear in the market this year such as a diagnostic reag...

KPMA opens membership to foreign drug companies.

The KPMA decided in the executive meeting on March 24 that the eligibility for KPMA membership widely opened to the foreign multinational drug companies regardless of the manufacturing facility located in Korea if the...

Pharmaceutical company increased cash account and reduced debt ratio.

According to "Financial analysis and investment advice of pharmaceutical industry" reported by Mr. Ha Tae-ki, the assistant manage in charge of pharmaceutical business, SK security company after analysing the financia...

M&A and Big Deals in pharmaceutical industry rootlessly rumoured

Rootless rumours widely spreaded that big deals between the top drug makers and M&A by domestic conglomerates were attempted, which was voiced loudly in the stock exchange market where "the confidential letter for int...

5 listed drug makers announced to give dividends.

The Korea Stock Exchange announced publicly that 5 drugs makers including Bukwang (fiscal year closed at Dec. 31, 1998) planned to pay dividends to their stockholders. Bukwang will pay 0.1 stock per a stock or in c...

Advertising and marketing promotion activity extremely slow due to IMF economic difficulties.

According to the financial analysis against KSE listed drug companies (account closing at Dec. 31), he advertising and market promotional expenditures in 1998 recorded extremely low by 33% and 20% decreases over the p...

KMA and KPA agreed to derive accorded medical/pharmacy separation bill in 2 months.

For celebration of the 45th anniversary of the Yakup Shinmoon Dr. Yu Sung-hee, the President of Korea Medical Association (KMA) and Mr. Kim Hee-joong, the President of Korea Pharmaceutical Association (KPA) were invit...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.